drugset / Trial / NCT02379000

TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy

NCT02379000

Phase 4 Unknown 50 enrolled Charite University, Berlin, Germany
RandomizedParallel-groupOpen-labelTreatment

Summary

Proton beam therapy is a safe irradiation modality for choroidal melanoma. But often after irradiation the exudation increases resulting in an exudative retinal detachment requiring vitreoretinal surgery. It is known that intravitreally injected triamcinolone and TTT is capable to decrease the exudation. If there is any advantage in a combined treatment this study will investigate.

Timeline

Start
2015-01
Primary completion
2017-12
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 4 mg Intravitreal